The optimization of clinical Characterization and microcosmic index about blood-stasis syndrome of coronary artery disease (CAD) -clinical cross sectional study

the key techonology of Evaluate clinical effect of Chinese medicine in the treatment of blood-stasis syndrome of CAD

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCS-11001594

Enrollment

Unknown

Registered

2011-06-23

Start date

2011-03-10

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blood-stasis syndrome of CAD

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with coronary artery disease and People without Coronary Heart Disease; 2. Aged between 40 to 75 years.

Exclusion criteria

Exclusion criteria: 1. affecting the data collection Due to mental, language and other factors; 2. Poor compliance, not Willing to participate in this observed study, or may dont complete this study; 3. participating in other clinical trials.

Design outcomes

Primary

Measure	Time frame
TCM sign;	—

Secondary

Measure	Time frame
Blood and urine routine examination, liver function;	—

Countries

China

Contacts

Public ContactShi Dazhuo

heartmail@263.com13511072856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026